130 related articles for article (PubMed ID: 18192131)
1. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine.
Chanda S; Sansgiry SS
J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131
[TBL] [Abstract][Full Text] [Related]
2. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
Emmerton L
J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
[TBL] [Abstract][Full Text] [Related]
3. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
[TBL] [Abstract][Full Text] [Related]
4. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
[TBL] [Abstract][Full Text] [Related]
5. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
[TBL] [Abstract][Full Text] [Related]
6. Readability of over-the-counter medication labels.
Sansgiry SS; Cady PS; Patil S
J Am Pharm Assoc (Wash); 1997; NS37(5):522-8. PubMed ID: 9479403
[TBL] [Abstract][Full Text] [Related]
7. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
[TBL] [Abstract][Full Text] [Related]
8. Consumer involvement: effects on information processing from over-the-counter medication labels.
Sansgiry SS; Cady PS; Sansgiry S
Health Mark Q; 2001; 19(1):61-78. PubMed ID: 11727293
[TBL] [Abstract][Full Text] [Related]
9. Willingness-to-accept pharmaceutical retail inconvenience: evidence from a contingent choice experiment.
Finlay K; Stoecker C; Cunningham S
PLoS One; 2015; 10(5):e0126790. PubMed ID: 26024444
[TBL] [Abstract][Full Text] [Related]
10. Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling.
Kimberlin CL; Jamison AN; Linden S; Winterstein AG
J Am Pharm Assoc (2003); 2011; 51(4):527-34. PubMed ID: 21752776
[TBL] [Abstract][Full Text] [Related]
11. Descriptive analysis of primary package labels from commercially available prescription solid oral dosage form drugs.
Chermak TE; Lambert BL
J Am Pharm Assoc (2003); 2009; 49(3):399-406. PubMed ID: 19443320
[TBL] [Abstract][Full Text] [Related]
12. The variability and quality of medication container labels.
Shrank WH; Agnew-Blais J; Choudhry NK; Wolf MS; Kesselheim AS; Avorn J; Shekelle P
Arch Intern Med; 2007 Sep; 167(16):1760-5. PubMed ID: 17846395
[TBL] [Abstract][Full Text] [Related]
13. Quality of medication information available on retail pharmacy Web sites.
Ghoshal M; Walji MF
Res Social Adm Pharm; 2006 Dec; 2(4):479-98. PubMed ID: 17161807
[TBL] [Abstract][Full Text] [Related]
14. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
Cunningham JK; Liu LM
Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
16. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
17. Health literacy assessment of labeling of pediatric nonprescription medications: examination of characteristics that may impair parent understanding.
Yin HS; Parker RM; Wolf MS; Mendelsohn AL; Sanders LM; Vivar KL; Carney K; Cerra ME; Dreyer BP
Acad Pediatr; 2012; 12(4):288-96. PubMed ID: 22579032
[TBL] [Abstract][Full Text] [Related]
18. The relevance of the urinary concentration of ephedrines in anti-doping analysis: determination of pseudoephedrine, cathine, and ephedrine after administration of over-the-counter medicaments.
Strano-Rossi S; Leone D; de la Torre X; Botrè F
Ther Drug Monit; 2009 Aug; 31(4):520-6. PubMed ID: 19571776
[TBL] [Abstract][Full Text] [Related]
19. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
Sansgiry SS; Chanda S; Shringarpure GS
Res Social Adm Pharm; 2007 Dec; 3(4):410-25. PubMed ID: 18082876
[TBL] [Abstract][Full Text] [Related]
20. Impacts of federal precursor chemical regulations on methamphetamine arrests.
Cunningham JK; Liu LM
Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
